Cargando…
Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer
BACKGROUND: Although chemotherapy represents a predominant anti-cancer therapeutic modality, drug treatment efficacy is often limited due to the development of resistant tumor cells. The pregnane X receptor (PXR) affects chemotherapeutic effects by regulating targets involved in drug metabolism and...
Autores principales: | Dong, Yan, Wang, Zhe, Xie, Gan-feng, Li, Chong, Zuo, Wen-wei, Meng, Gang, Xu, Cheng-ping, Li, Jian-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372326/ https://www.ncbi.nlm.nih.gov/pubmed/28356150 http://dx.doi.org/10.1186/s12943-017-0641-8 |
Ejemplares similares
-
Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant
por: Li, Tingting, et al.
Publicado: (2016) -
Effect of pregnane X receptor expression on drug resistance in breast cancer
por: QIAO, EN-QI, et al.
Publicado: (2014) -
Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis
por: Arroyo, Luiz Henrique, et al.
Publicado: (2019) -
Bioguided Isolation of Antibiofilm and Antibacterial Pregnane Glycosides from Caralluma quadrangula: Disarming Multidrug-Resistant Pathogens
por: El-Shiekh, Riham A., et al.
Publicado: (2021) -
Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor
por: Rao, Zhou-Zhou, et al.
Publicado: (2023)